Mesothelioma Trials: FR901228 and Flavopiridol

Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.

If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.

The National Cancer Institute is currently conducting a clinical trial of two chemotherapy drugs, FR901228 and Flavopiridol. The Institute is seeking patients with mesothelioma, lung cancer and/or esophageal cancer to participate in the study.

The purpose of the Phase I trial is to determine the side effects and most effective dosage of FR901228 when given in combination with Flavopiridol.

The study is currently being conducted at the NCI-Center for Cancer Research and the Warrant Grant Magnuson Clinical Center. Both facilities are located in Bethesda, Maryland. More information about this study may be obtained by contacting the study chair, David S. Schrump, M.D. at the NCI facility.

Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease.

If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.